Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 139

1.

Mutational spectrum of the SERPING1 gene in Swiss patients with hereditary angioedema.

Steiner UC, Keller M, Schmid P, Cichon S, Wuillemin WA.

Clin Exp Immunol. 2017 Feb 14. doi: 10.1111/cei.12941. [Epub ahead of print]

PMID:
28194776
2.

Praktische Tipps und Tricks zu den DOAC.

Simeon L, Wuillemin WA.

Ther Umsch. 2016;73(10):561-566. doi: 10.1024/0040-5930/a000839. German. No abstract available.

PMID:
28045358
4.

Hereditary angioedema due to C1 - inhibitor deficiency in Switzerland: clinical characteristics and therapeutic modalities within a cohort study.

Steiner UC, Weber-Chrysochoou C, Helbling A, Scherer K, Grendelmeier PS, Wuillemin WA.

Orphanet J Rare Dis. 2016 Apr 21;11:43. doi: 10.1186/s13023-016-0423-1.

5.

Complement Factor H-Related Protein 3 Serum Levels Are Low Compared to Factor H and Mainly Determined by Gene Copy Number Variation in CFHR3.

Pouw RB, Brouwer MC, Geissler J, van Herpen LV, Zeerleder SS, Wuillemin WA, Wouters D, Kuijpers TW.

PLoS One. 2016 Mar 23;11(3):e0152164. doi: 10.1371/journal.pone.0152164.

6.

Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis.

Versluis J, Hazenberg CL, Passweg JR, van Putten WL, Maertens J, Biemond BJ, Theobald M, Graux C, Kuball J, Schouten HC, Pabst T, Löwenberg B, Ossenkoppele G, Vellenga E, Cornelissen JJ; HOVON and SAKK Leukemia Groups..

Lancet Haematol. 2015 Oct;2(10):e427-36. doi: 10.1016/S2352-3026(15)00148-9.

PMID:
26686044
7.

The Swiss National Registry for Primary Immunodeficiencies: report on the first 6 years' activity from 2008 to 2014.

Marschall K, Hoernes M, Bitzenhofer-Grüber M, Jandus P, Duppenthaler A, Wuillemin WA, Rischewski J, Boyman O, Heininger U, Hauser T, Steiner U, Posfay-Barbe K, Seebach J, Recher M, Hess C, Helbling A, Reichenbach J; Swiss PID Registry Working Group..

Clin Exp Immunol. 2015 Oct;182(1):45-50. doi: 10.1111/cei.12661.

8.

Reference values for oral iron absorption of bivalent iron in healthy volunteers.

Kloepfer K, Schmid P, Wuillemin WA, Rüfer A.

Swiss Med Wkly. 2015 Jan 22;145:w14063. doi: 10.4414/smw.2015.14063.

9.

Predictors of thromboprophylaxis in hospitalised medical patients. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE).

Spirk D, Nendaz M, Aujesky D, Hayoz D, Beer JH, Husmann M, Frauchiger B, Korte W, Wuillemin WA, Righini M, Bounameaux H, Kucher N.

Thromb Haemost. 2015 May;113(5):1127-34. doi: 10.1160/TH14-06-0525.

PMID:
25608607
10.
11.

Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.

Nagler M, Bachmann LM, Schmid P, Raddatz Müller P, Wuillemin WA.

PLoS One. 2014 Apr 18;9(4):e95761. doi: 10.1371/journal.pone.0095761.

12.

Complexes of factor VII-activating protease with plasminogen activator inhibitor-1 in human sepsis.

Stephan F, Bulder I, Luken BM, Hazelzet J, Wuillemin WA, Zeerleder S.

Thromb Haemost. 2014 Jul 3;112(1):219-21. doi: 10.1160/TH13-12-1062. No abstract available.

PMID:
24651925
13.

Consistency of thromboelastometry analysis under scrutiny: results of a systematic evaluation within and between analysers.

Nagler M, ten Cate H, Kathriner S, Casutt M, Bachmann LM, Wuillemin WA.

Thromb Haemost. 2014 Jun;111(6):1161-6. doi: 10.1160/TH13-10-0870.

PMID:
24477424
14.

[New oral anticoagulants - influence on coagulation tests].

Simeon L, Nagler M, Wuillemin WA.

Dtsch Med Wochenschr. 2014 Jan;139(3):94-9. doi: 10.1055/s-0033-1359920. German.

PMID:
24399657
15.

Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE).

Nendaz M, Spirk D, Kucher N, Aujesky D, Hayoz D, Beer JH, Husmann M, Frauchiger B, Korte W, Wuillemin WA, Jäger K, Righini M, Bounameaux H.

Thromb Haemost. 2014 Mar 3;111(3):531-8. doi: 10.1160/TH13-05-0427.

PMID:
24226257
16.

[Questions and answers regarding the use of rivaroxaban in daily practice].

groupe de travail RivaMoS Suisse.; groupe Working Party on Haemostasis de la Société suisse d'hématologie..

Rev Med Suisse. 2013 Jun 26;9(392):1375-85. French.

PMID:
23882916
17.

[Pitfall in coagulation tests].

Gähler A, Wuillemin WA.

Ther Umsch. 2013 Aug;70(8):443-8. doi: 10.1024/0040-5930/a000430. Review. German.

PMID:
23876750
18.

Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study.

Nagler M, Bachmann LM, Alberio L, Angelillo-Scherrer A, Asmis LM, Korte W, Mendez A, Reber G, Stricker H, Tsakiris DA, Wuillemin WA.

Thromb J. 2013 Mar 7;11(1):6. doi: 10.1186/1477-9560-11-6.

19.

[The spleen in non-malignant haematological disorders].

Rüfer A, Wuillemin WA.

Ther Umsch. 2013 Mar;70(3):157-62. doi: 10.1024/0040-5930/a000384. Review. German.

PMID:
23454562
20.

Impact of changes in haematocrit level and platelet count on thromboelastometry parameters.

Nagler M, Kathriner S, Bachmann LM, Wuillemin WA.

Thromb Res. 2013 Mar;131(3):249-53. doi: 10.1016/j.thromres.2013.01.009.

PMID:
23347682

Supplemental Content

Loading ...
Support Center